A

Ariceum Therapeutics

18 employees

Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Medical

Date founded

2021

Funding rounds raised

Total raised

$27M

from 3 investors over 3 rounds

A

Ariceum Therapeutics raised $27M on June 8, 2022

Investors: Pureos Bioventures, HealthCap and EQT Life Sciences

FAQ